December 08, 2025 a 09:00 pm
GEHC: Analysts Ratings - GE HealthCare Technologies Inc.
GE HealthCare Technologies Inc. has shown a robust market position with a consistent focus on providing innovative medical solutions. Analysts' ratings indicate a generally positive sentiment with predominant Buy recommendations. The company’s broad operational reach and diverse product segments contribute to its compelling investment profile, though the reliance on market penetration and technology advancements requires ongoing attention.
Historical Stock Grades
| Rating | Number of Recommendations | Score Bar |
|---|---|---|
| Strong Buy | 3 | |
| Buy | 11 | |
| Hold | 7 | |
| Sell | 0 | |
| Strong Sell | 0 |
Image illustrating historical trends in analyst ratings for GE HealthCare Technologies Inc.
Stock price chart for GE HealthCare Technologies Inc. over the past months.
Sentiment Development
The sentiment surrounding GEHC has exhibited consistency in ratings, with notable stability in Buy and Hold categories. There has been a slight reduction in Buy recommendations over recent months. Strong Buy ratings have remained steady, indicating moderate confidence. Key takeaways include:
- The overall sentiment remains positive, with no recommendations to sell.
- Strong Buy ratings maintain a stable presence with three analysts.
- Hold recommendations have seen a slight increase, suggesting a cautious market sentiment.
Percentage Trends
Analyzing the ratings in percentage terms provides insight into shifts in analyst sentiment. There has been a minor decrease in Buy recommendations from 57% to approximately 52% from October to December 2025. The Hold category rose to occupy a larger share, indicating a more conservative stance from some analysts.
- Strong Buy: Stable at approximately 14%.
- Buy: Declined slightly from 62% to 58% over the past few months.
- Hold: Slight increase from 24% to 26% reflecting caution in assessment.
- No Sell or Strong Sell ratings, which is a positive indicator.
- The overall confidence remains high with predominant Buy ratings.
Latest Analyst Recommendations
The most recent analyst recommendations show a trend of stability, with firms maintaining their previous positions. No significant shifts in opinion are noted, reinforcing confidence in GEHC's current performance. Here are the latest recommendations:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-11-21 | Buy | Buy | BTIG |
| 2025-10-30 | Outperform | Outperform | Evercore ISI Group |
| 2025-10-30 | Equal Weight | Equal Weight | Morgan Stanley |
| 2025-10-30 | Overweight | Overweight | Wells Fargo |
| 2025-10-13 | Buy | Buy | BTIG |
Analyst Recommendations with Change of Opinion
Several analysts have adjusted their outlook on GEHC, reflecting a dynamic market response. These changes can suggest adjustments to economic indicators or internal company developments. Noteworthy changes include:
| Date | New Recommendation | Last Recommendation | Publisher |
|---|---|---|---|
| 2025-10-07 | Neutral | Buy | Citigroup |
| 2025-05-05 | Neutral | Sell | UBS |
| 2025-03-11 | Buy | Neutral | Goldman Sachs |
| 2025-01-08 | Buy | Hold | Jefferies |
| 2024-09-26 | Sell | Neutral | UBS |
Interpretation
The current analyst sentiment suggests a strong confidence in GE HealthCare Technologies Inc., underpinned by a solid prevalence of Buy ratings. Despite minor fluctuations, the lack of Sell recommendations indicates a favorable outlook. The mix of stable and upgraded downgrades reflects normal market recalibrations rather than significant concerns. A consistent Buy indicates sustained trust amid market fluctuations, yet vigilance for more macroeconomic shifts or internal changes is prudent.
Conclusion
GE HealthCare Technologies Inc. remains a compelling stock choice, buoyed by a broad operational reach and diverse product segments. The influence of technological advancements and geographic expansion denotes opportunities with some inherent risks from competitive pressures and market dynamics. Analyst ratings reflect cautious optimism with dominant Buy positions and insignificant Sell indicators. Understanding the fluctuating market and analyst recommendations can guide strategic investment decisions. GEHC's consistent analyst confidence adds assurance for investors seeking long-term stability and growth potential.